Results of a family survey on healthcare resource needs in children with neuronal ceroid lipofuscinosis type 2 (CLN2) disease in the US and Canada

被引：0
|
作者：
Rastogi, Sarang [1 ]
Conner, Therese [2 ]
Cook, Francesca [1 ]
Fernandez, Vivian [1 ]
Kirby, Tracy [3 ]
机构：
[1] REGENXBIO Inc, Rockville, MD USA
[2] Xcenda, Palm Harbor, FL USA
[3] BDSRA, Columbus, OH USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2020年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2019.11.354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
345
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [21] Correction: An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
    Dorothy A. Thompson
    Siân E. Handley
    Robert H. Henderson
    Oliver R. Marmoy
    Paul Gissen
    Eye, 2021, 35 : 2912 - 2912
  • [22] Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
    Nickel, Miriam
    Simonati, Alessandro
    Jacoby, David
    Lezius, Susanne
    Kilian, Dirk
    Van de Graaf, Benjamin
    Pagovich, Odelya E.
    Kosofsky, Barry
    Yohay, Kaleb
    Downs, Matthew
    Slasor, Peter
    Aiayi, Temitayo
    Crystal, Ronald G.
    Kohlschuetter, Alfried
    Sondhi, Dolan
    Schulz, Angela
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08): : 582 - 590
  • [23] Intravitreal enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2)
    Sinclair, John
    Whiting, Rebecca
    Robinson, Grace
    Bibi, Katherine
    Nguyen, Annailsa
    Cherukuri, Anu
    Henshaw, Joshua
    De Hart, Gregory
    Chandra, Sundeep
    O'Neill, Chuck
    Katz, Martin
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S132 - S132
  • [24] Intravitreal Enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2)
    Sinclair, John
    Whiting, Rebecca
    Robinson, Grace
    Bibi, Katherin
    Nguyen, Annalisa
    Cherukuri, Anu
    Henshaw, Joshua
    de Hart, Gregory
    Sundeep, Chandra
    O'Neil, Chuck
    Katz, Martin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [25] Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
    Gutic, Medo
    Milosavljevic, Milos N.
    Safiye, Teodora
    Milidrag, Ardea
    Jankovic, Slobodan M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 561 - 570
  • [26] Neuronal ceroid lipofuscinosis type CLN2: A new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America
    Kohan, Romina
    Noelia Carabelos, Maria
    Xin, Winnie
    Sims, Katherine
    Guelbert, Norberto
    Adriana Cismondi, Ines
    Pons, Patricia
    Irene Alonso, Graciela
    Troncoso, Monica
    Witting, Scarlet
    Pearce, David A.
    Dodelson de Kremer, Raquel
    Maria Oller-Ramirez, Ana
    Noher de Halac, Ines
    GENE, 2013, 516 (01) : 114 - 121
  • [27] VALPROIC ACID EXTENDS LIFESPAN OF THE ZEBRAFISH MODEL OF CLN2 DISEASE (LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS)
    Mahmood, Fahad
    Zdebik, Anselm
    Au, Alexandra
    Cooke, Jennifer
    Russell, Claire
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [28] Novel method for evaluating functional vision in a canine model of CLN2 neuronal ceroid lipofuscinosis
    Gillespie, Lauren Elizabeth
    Whiting, Rebecca E. H.
    Lewis, Haley N.
    Castaber, Keukabu H.
    Katz, Martin L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] The expression of late infantile neuronal ceroid lipofuscinosis (CLN2) gene product in human brains
    Oka, A
    Kurachi, Y
    Mizuguchi, M
    Hayashi, M
    Takashima, S
    NEUROSCIENCE LETTERS, 1998, 257 (02) : 113 - 115
  • [30] Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis
    Zhong, N
    Wisniewski, KE
    Hartikainen, J
    Ju, W
    Moroziewicz, DN
    McLendon, L
    Brooks, SS
    Brown, WT
    CLINICAL GENETICS, 1998, 54 (03) : 234 - 238
12345